Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution...
Reexamination Certificate
2004-12-22
2008-08-12
Tate, Christopher R. (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
C424S773000
Reexamination Certificate
active
07410658
ABSTRACT:
The present invention describes compositions and methods for improving the appearance of skin, particularly, treating, preventing, ameliorating, reducing and/or eliminating excess accumulation or production of subcutaneous fat, such as cellulite, or conditions related to excess accumulation, production, or excretion of sebum, such as acne, an oily complexion, oily hair or scalp, or undesirable body odor, by topically applying compositions comprisingAlisma orientateconstituents, or extracts therefrom.
REFERENCES:
patent: 4379454 (1983-04-01), Campbell et al.
patent: 4820724 (1989-04-01), Nimni
patent: 4956171 (1990-09-01), Chang
patent: 5146846 (1992-09-01), Lee et al.
patent: 5223262 (1993-06-01), Kim et al.
patent: 5595743 (1997-01-01), Wu
patent: 5770222 (1998-06-01), Unger et al.
patent: 5834513 (1998-11-01), Ptchelintsev et al.
patent: 5847003 (1998-12-01), Ptchelintsev et al.
patent: 6790464 (2004-09-01), Kuok et al.
patent: 6933291 (2005-08-01), Qi et al.
patent: 2002/0031559 (2002-03-01), Liang et al.
patent: 2004/0247654 (2004-12-01), Asmus et al.
patent: 2005/0142231 (2005-06-01), Gong et al.
patent: 2006/0018867 (2006-01-01), Kawasaki et al.
patent: 1104479 (1995-07-01), None
patent: 1105557 (1995-07-01), None
patent: 1267472 (2000-09-01), None
patent: 1286924 (2001-03-01), None
patent: 09087187 (1997-03-01), None
patent: 10045613 (1998-02-01), None
patent: 2004-035442 (2004-02-01), None
patent: 2004035442 (2004-02-01), None
patent: WO 01/66067 (2001-09-01), None
Nedvidkova J, et al. “Adiponectin, an adipocyte-derived protein” Physiol Res., Nov. 15, 2004.
Gil-Campos M M, et al. “Adiponectin, the missing link in insulin resistance and obesity” Clin Nutr. 23(5):963-74, 2004.
Putz DM, et al. “Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy” Metabolism 53(11):1454-61, 2004.
Shetty GK, et al. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, . . . Diabetes Care. 27(10):2450-7,2004.
Schulze MB, et al. “Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes” Diabetes Care. 27(7):1680-7,2004.
Meier U & Gressner AM. “Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects . . . ” Clin Chem. 50(9):1511-25, 2004.
Hines Michelle D.
Wang Helen H.
Avon Products Inc.
McGillycuddy Joan M.
Santini Anthony M.
Tate Christopher R.
Zeller Charles J.
LandOfFree
Use of Alisma orientale in cosmetics and compositions thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of Alisma orientale in cosmetics and compositions thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of Alisma orientale in cosmetics and compositions thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3996113